vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and MAGNACHIP SEMICONDUCTOR Corp (MX). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $40.6M, roughly 1.1× MAGNACHIP SEMICONDUCTOR Corp). MAGNACHIP SEMICONDUCTOR Corp runs the higher net margin — -19.9% vs -19.9%, a 0.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -20.7%). MAGNACHIP SEMICONDUCTOR Corp produced more free cash flow last quarter ($-4.8M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -3.4%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Magnachip Semiconductor Corp is a global semiconductor design and manufacturing firm specializing in high-performance analog and mixed-signal solutions. Its core products include display driver ICs, power management ICs and sensors, serving consumer electronics, automotive, industrial and communications markets worldwide.

ABCL vs MX — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.1× larger
ABCL
$44.9M
$40.6M
MX
Growing faster (revenue YoY)
ABCL
ABCL
+809.1% gap
ABCL
788.4%
-20.7%
MX
Higher net margin
MX
MX
0.0% more per $
MX
-19.9%
-19.9%
ABCL
More free cash flow
MX
MX
$39.8M more FCF
MX
$-4.8M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-3.4%
MX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
MX
MX
Revenue
$44.9M
$40.6M
Net Profit
$-8.9M
$-8.1M
Gross Margin
9.3%
Operating Margin
-63.7%
-26.1%
Net Margin
-19.9%
-19.9%
Revenue YoY
788.4%
-20.7%
Net Profit YoY
73.9%
50.4%
EPS (diluted)
$-0.03
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
MX
MX
Q4 25
$44.9M
$40.6M
Q3 25
$9.0M
$45.9M
Q2 25
$17.1M
$47.6M
Q1 25
$4.2M
$44.7M
Q4 24
$5.0M
$51.2M
Q3 24
$6.5M
$55.4M
Q2 24
$7.3M
$46.4M
Q1 24
$10.0M
$43.4M
Net Profit
ABCL
ABCL
MX
MX
Q4 25
$-8.9M
$-8.1M
Q3 25
$-57.1M
$-13.1M
Q2 25
$-34.7M
$323.0K
Q1 25
$-45.6M
$-8.9M
Q4 24
$-16.3M
Q3 24
$-51.1M
$-9.6M
Q2 24
$-36.9M
$-13.0M
Q1 24
$-40.6M
$-15.4M
Gross Margin
ABCL
ABCL
MX
MX
Q4 25
9.3%
Q3 25
18.6%
Q2 25
20.4%
Q1 25
20.9%
Q4 24
21.7%
Q3 24
20.8%
Q2 24
21.1%
Q1 24
14.6%
Operating Margin
ABCL
ABCL
MX
MX
Q4 25
-63.7%
-26.1%
Q3 25
-851.8%
-25.1%
Q2 25
-290.2%
-15.6%
Q1 25
-1479.6%
-14.1%
Q4 24
-12.5%
Q3 24
-1439.4%
-8.1%
Q2 24
-1276.2%
-12.3%
Q1 24
-551.5%
-21.6%
Net Margin
ABCL
ABCL
MX
MX
Q4 25
-19.9%
-19.9%
Q3 25
-637.8%
-28.5%
Q2 25
-203.3%
0.7%
Q1 25
-1077.2%
-19.9%
Q4 24
-31.8%
Q3 24
-785.4%
-17.3%
Q2 24
-504.3%
-28.0%
Q1 24
-408.0%
-35.5%
EPS (diluted)
ABCL
ABCL
MX
MX
Q4 25
$-0.03
$-0.23
Q3 25
$-0.19
$-0.36
Q2 25
$-0.12
$0.01
Q1 25
$-0.15
$-0.24
Q4 24
$-0.44
Q3 24
$-0.17
$-0.26
Q2 24
$-0.13
$-0.34
Q1 24
$-0.14
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
MX
MX
Cash + ST InvestmentsLiquidity on hand
$128.5M
$103.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$248.3M
Total Assets
$1.4B
$351.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
MX
MX
Q4 25
$128.5M
$103.8M
Q3 25
$83.2M
$108.0M
Q2 25
$92.4M
$113.3M
Q1 25
$159.3M
$132.7M
Q4 24
$156.3M
$138.6M
Q3 24
$126.6M
$151.1M
Q2 24
$148.3M
$162.5M
Q1 24
$123.6M
$171.6M
Stockholders' Equity
ABCL
ABCL
MX
MX
Q4 25
$966.9M
$248.3M
Q3 25
$964.0M
$255.3M
Q2 25
$1.0B
$270.2M
Q1 25
$1.0B
$269.2M
Q4 24
$1.1B
$276.8M
Q3 24
$1.1B
$299.6M
Q2 24
$1.1B
$305.8M
Q1 24
$1.1B
$321.9M
Total Assets
ABCL
ABCL
MX
MX
Q4 25
$1.4B
$351.5M
Q3 25
$1.4B
$359.6M
Q2 25
$1.4B
$370.5M
Q1 25
$1.3B
$373.9M
Q4 24
$1.4B
$379.3M
Q3 24
$1.4B
$411.4M
Q2 24
$1.4B
$412.7M
Q1 24
$1.5B
$426.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
MX
MX
Operating Cash FlowLast quarter
$-34.7M
$5.4M
Free Cash FlowOCF − Capex
$-44.6M
$-4.8M
FCF MarginFCF / Revenue
-99.4%
-11.9%
Capex IntensityCapex / Revenue
21.9%
25.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$-54.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
MX
MX
Q4 25
$-34.7M
$5.4M
Q3 25
$-52.6M
$162.0K
Q2 25
$-32.4M
$-25.1M
Q1 25
$-11.6M
$-4.7M
Q4 24
$-108.6M
$11.9M
Q3 24
$-28.9M
$-12.9M
Q2 24
$-30.0M
$-1.1M
Q1 24
$-41.7M
$-4.0M
Free Cash Flow
ABCL
ABCL
MX
MX
Q4 25
$-44.6M
$-4.8M
Q3 25
$-61.5M
$-7.5M
Q2 25
$-45.8M
$-37.0M
Q1 25
$-22.2M
$-4.9M
Q4 24
$-187.0M
$4.4M
Q3 24
$-47.4M
$-15.5M
Q2 24
$-50.1M
$-2.0M
Q1 24
$-65.8M
$-4.6M
FCF Margin
ABCL
ABCL
MX
MX
Q4 25
-99.4%
-11.9%
Q3 25
-687.0%
-16.3%
Q2 25
-267.9%
-77.7%
Q1 25
-524.0%
-10.9%
Q4 24
-3702.8%
8.7%
Q3 24
-728.4%
-28.0%
Q2 24
-683.8%
-4.3%
Q1 24
-661.5%
-10.7%
Capex Intensity
ABCL
ABCL
MX
MX
Q4 25
21.9%
25.3%
Q3 25
99.7%
16.7%
Q2 25
78.2%
24.9%
Q1 25
251.1%
0.5%
Q4 24
1552.7%
14.5%
Q3 24
284.6%
4.7%
Q2 24
274.6%
1.9%
Q1 24
242.5%
1.5%
Cash Conversion
ABCL
ABCL
MX
MX
Q4 25
Q3 25
Q2 25
-77.81×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

MX
MX

Power Analog Solutions$36.8M91%
Power Ic$3.8M9%

Related Comparisons